Detalles de la búsqueda
1.
Antibodies against human cytomegalovirus late protein UL94 in the pathogenesis of scleroderma-like skin lesions in chronic graft-versus-host disease.
Int Immunol
; 24(9): 583-91, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22773152
2.
Plerixafor and Filgrastim XM02 (Tevagastrim) as a first line peripheral blood stem cell mobilisation strategy in patients with multiple myeloma and lymphoma candidated to autologous bone marrow transplantation.
Eur J Haematol
; 88(2): 154-8, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21992403
3.
Who should be really considered as a poor mobilizer in the plerixafor era?
Transfus Apher Sci
; 47(1): 27-32, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22480954
4.
Circulating perivascular progenitors: a target of PDGFR inhibition.
Int J Cancer
; 129(6): 1344-50, 2011 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21128230
5.
Molecular and functional analysis of the stem cell compartment of chronic myelogenous leukemia reveals the presence of a CD34- cell population with intrinsic resistance to imatinib.
Blood
; 114(25): 5191-200, 2009 Dec 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-19855080
6.
Validation of a standardized method for enumerating circulating endothelial cells and progenitors: flow cytometry and molecular and ultrastructural analyses.
Clin Cancer Res
; 15(1): 267-73, 2009 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19118054
7.
A single dose of Pegfilgrastim versus daily Filgrastim to evaluate the mobilization and the engraftment of autologous peripheral hematopoietic progenitors in malignant lymphoma patients candidate for high-dose chemotherapy.
Transfus Apher Sci
; 43(3): 321-326, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21036667
8.
Human acute leukemia cells injected in NOD/LtSz-scid/IL-2Rgamma null mice generate a faster and more efficient disease compared to other NOD/scid-related strains.
Int J Cancer
; 123(9): 2222-7, 2008 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18688847
9.
Adipose Progenitor Cell Secretion of GM-CSF and MMP9 Promotes a Stromal and Immunological Microenvironment That Supports Breast Cancer Progression.
Cancer Res
; 77(18): 5169-5182, 2017 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28754674
10.
CXCR4 neutralization, a novel therapeutic approach for non-Hodgkin's lymphoma.
Cancer Res
; 62(11): 3106-12, 2002 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-12036921
11.
Assessing tumor angiogenesis: increased circulating VE-cadherin RNA in patients with cancer indicates viability of circulating endothelial cells.
Cancer Res
; 64(12): 4373-7, 2004 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15205354
12.
Mammaglobin expression in leukapheresis products is a predictive marker of poor prognosis in women with high-risk breast cancer.
Clin Cancer Res
; 10(18 Pt 1): 6039-46, 2004 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15447988
13.
In vitro and in vivo hematopoietic potential of human stem cells residing in muscle tissue.
Exp Hematol
; 30(8): 905-14, 2002 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-12160842
14.
Molecular investigation of coexistent chronic myeloid leukaemia and peripheral T-cell lymphoma - a case report.
Sci Rep
; 5: 14829, 2015 Oct 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26439403
15.
Antiangiogenic therapy in recurrent breast cancer with lymphangitic spread to the chest wall: A randomized phase II trial of bevacizumab with sequential or concurrent oral vinorelbine and capecitabine.
Breast
; 24(3): 263-71, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25772326
16.
Blood-based biomarkers for the optimization of anti-angiogenic therapies.
Cancers (Basel)
; 2(2): 1027-39, 2010 May 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-24281105
17.
Angiogenic cells, macroparticles and RNA transcripts in laparoscopic vs open surgery for colorectal cancer.
Cancer Biol Ther
; 10(7): 682-5, 2010 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20676027
18.
Rituximab and subcutaneous cladribine in chronic lymphocytic leukemia for newly diagnosed and relapsed patients.
Leuk Lymphoma
; 51(8): 1485-93, 2010 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-20578816
19.
Rituximab and subcutaneous 2-chloro-2'-deoxyadenosine combination treatment for patients with Waldenstrom macroglobulinemia: clinical and biologic results of a phase II multicenter study.
J Clin Oncol
; 28(13): 2233-8, 2010 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20368573
20.
Predictive Potential of Angiogenic Growth Factors and Circulating Endothelial Cells in Breast Cancer Patients Receiving Metronomic Chemotherapy Plus Bevacizumab.
Clin Cancer Res
; 15(24): 7652-7657, 2009 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-19996223